Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial
2019 ◽
Vol 21
(10)
◽
pp. 2284-2293
◽
Keyword(s):
Phase 3
◽
1999 ◽
Vol 16
(3)
◽
pp. 228-232
◽
Keyword(s):
2018 ◽
Vol 142
◽
pp. 1-9
◽